Home » Newsletters » BioWorld Science

BioWorld Science

May 14, 1999

View Archived Issues

Company Profile: NeuroVir

Chromium picolinate identified as insulin assistance factor

La Jolla presents new Toleragen compound with potential to treat autoimmune blood clotting disorder

Genset signs collaboration with Johns Hopkins for schizophrenia gene identification

Roberts will distribute emergency contraceptive kit in Canada

Phase III trial results presented for Leukine in AIDS

Postmarketing studies of latanoprost support efficacy, safety of antiglaucoma agent

Microtubule disruption by T-138067 produces potent anticancer activity in MDR tumors

Cholesteryl ester transfer protein inhibitors patented by Bayer

Antiinflammatory and analgesic pyrazoles described by Fujisawa

Roche team synthesizes new series of PLA2 inhibitors

Glaxo reports kinase inhibitors especially useful for chemotherapy-induced alopecia

Vitronectin receptor antagonists from SB for osteoporosis, cancer, etc.

Cytokine-inhibitory aminotetralines synthesized and evaluated at Sigma-Tau

OraVax and Peptide Therapeutics merger completed this week

Clinical trials of OP-2000 for IBD to begin later this year

IntraDose NDA to receive fast track review by FDA

RB-2121, an anti-HIV agent directed to a novel antiretroviral target

RFS-2000 (now rubitecan) advances in clinical trials in over 10 tumor types

ONYX-015 now under clinical evaluation for chemopreventive potential

RD3-0028 is effective in treating RSV infection in mice

Periodontix announces phase I/II trial of histatin-based mouthwash for oral candidiasis

Planned accelerated full merger of Rhone-Poulenc and Hoechst moves ahead

Approvable letter for Exelon NDA issued by FDA

Company Profile: Message Pharmaceuticals

U.S. patent issues to Cytogen for PSMA-specific abtides

Tranilast evaluated in dog model of intimal hyperplasia following vascular injury

Ribi ImmunoChem: Q1 1999 highlights

DSMB approves continuation of phase III trial of Flocor in sickle cell crisis

Genzyme Molecular Oncology outlines development plans at recent analysts meeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...